I have two quick points.
A bad deal is a secret price deal for which nobody knows whether it's good. It's the poor 25%, the most vulnerable of our population that have no insurance at all, who are losing. That is a tragedy. A good deal, and a good example I can think of, is a reduced price on a drug that may have a benefit for dementia. If the patient does not benefit from the drug, the company is paying the whole shot and is rebating. I think this notion of advancing our thinking is to look at what value we want out of these price deals clinically, as well as with cost reduction.